Validation Study of Retrospective Recall of Disease-Targeted Function
- 1 August 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Medical Care
- Vol. 38 (8) , 847-857
- https://doi.org/10.1097/00005650-200008000-00008
Abstract
This was an ancillary methodological study within the Prostate Cancer Outcomes Study (PCOS) to assess the validity of 6-month retrospective recall of prediagnostic disease-targeted function among men diagnosed with prostate cancer. A convenience sample of 133 prostate cancer cases were administered a baseline questionnaire shortly after diagnosis that asked about prediagnostic urinary, sexual, and bowel function. They were surveyed again concerning the same items 6 months later and asked to recall their prediagnostic function. Reports of prediagnostic function obtained at baseline and 6 months are compared, as are measures of change derived from these reports. Percent agreement and weighted kappas are calculated to measure the extent of agreement. Over 70% of the men reported prediagnostic functioning at the highest level on 12 of 17 survey items. For each of these items, recall at 6 months was identical to the baseline survey response for > or =69% of the men. The values of the weighted kappas for changes computed with baseline reports (prospective) and changes computed with 6-month recall (retrospective) ranged from 0.396 to 0.919 for the 17 individual items. Intraclass correlations for the retrospective versus prospective changes in the multi-item function scores were 0.828 for urinary, 0.618 for bowel, and 0.692 for sexual function. At baseline, men recently diagnosed with prostate cancer report few disease-related problems before diagnosis, and a high percentage of men recall this accurately 6 months later. There is reasonably high agreement between baseline and 6-month estimates of prediagnostic function and between prospective and retrospective measures of change over 6 months.Keywords
This publication has 24 references indexed in Scilit:
- Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.Journal of Clinical Oncology, 1998
- CLINICAL GUIDELINES: PART II: Early Detection of Prostate Cancer: Part IIAnnals of Internal Medicine, 1997
- Controversies in prostate cancer screening. Analogies to the early lung cancer screening debatePublished by American Medical Association (AMA) ,1996
- Screening for prostate cancer. A decision analytic viewPublished by American Medical Association (AMA) ,1994
- Prostate Cancer Screening: What We Know and What We Need To KnowAnnals of Internal Medicine, 1993
- Return of Erections and Urinary Continence Following Nerve Sparing Radical Retropubic ProstatectomyJournal of Urology, 1993
- Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screeningPublished by American Medical Association (AMA) ,1993
- A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research TeamPublished by American Medical Association (AMA) ,1993
- Quality of Life after Radical Retropubic Prostatectomy for Carcinoma of the ProstateEuropean Urology, 1993
- Potency Following Radical Prostatectomy with Wide Unilateral Excision of the Neurovascular BundleJournal of Urology, 1987